{"disease":{"id":"sensitive-pulmonary-tuberculosis","name":"sensitive pulmonary tuberculosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04670120","title":"Early Bactericidal Activity Safety Pulmonary Tuberculosis Pyrifazimine (TBI-166)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":56,"lead_sponsor_name":"Beijing Chest Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}